Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Testing (POCT) Market 

5.1. COVID-19 Landscape: Point-of-Care Testing (POCT) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Testing (POCT) Market, By Product Type

8.1. Point-of-Care Testing (POCT) Market, by Product Type, 2022-2030

8.1.1. Covid -19 testing kits

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Glucose monitoring products

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Cardiometabolic Monitoring Products

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Infectious disease testing products

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Coagulation monitoring products

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Pregnancy and fertility testing products

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Pregnancy testing products

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Fertility testing products

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Cancer marker testing products

8.1.9.1. Market Revenue and Forecast (2017-2030)

8.1.10. Urinanalysis testing products

8.1.10.1. Market Revenue and Forecast (2017-2030)

8.1.11. Cholestrol testing products

8.1.11.1. Market Revenue and Forecast (2017-2030)

8.1.12. Hematology testing products

8.1.12.1. Market Revenue and Forecast (2017-2030)

8.1.13. Drugs-of-abuse testing products

8.1.13.1. Market Revenue and Forecast (2017-2030)

8.1.14. Fecal Occult testing products

8.1.14.1. Market Revenue and Forecast (2017-2030)

8.1.15. Others

8.1.15.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Point-of-Care Testing (POCT) Market, By Platform

9.1. Point-of-Care Testing (POCT) Market, by Platform, 2022-2030

9.1.1. Lateral Flow Assays

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dipsticks

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Microfluids

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Molecular Diagnostics

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Immunoassays

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Point-of-Care Testing (POCT) Market, By Mode of Purchase 

10.1. Point-of-Care Testing (POCT) Market, by Mode of Purchase, 2022-2030

10.1.1. OTC products

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Prescribed based products

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Point-of-Care Testing (POCT) Market, By Testing Type

11.1. Point-of-Care Testing (POCT) Market, by Testing Type, 2022-2030

11.1.1. Immunoassays

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cell-Based Assays

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Nucleic Acid Amplification Testing

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Clinical Chemistry Assays

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Hematology

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Point-of-Care Testing (POCT) Market, By End-User

12.1. Point-of-Care Testing (POCT) Market, by End-User, 2022-2030

12.1.1. Clinical laboratories

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Ambulatory care facilities and physician offices

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Pharmacies, retail clinics & E-comm platforms

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Hospitals, Critical care centres, Urgent care centres

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Home care & self-testing

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Point-of-Care Testing (POCT) Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Platform (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.4. Market Revenue and Forecast, by Testing Type (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.7. Market Revenue and Forecast, by Testing Type (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.10. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.11. Market Revenue and Forecast, by End-User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.13. Market Revenue and Forecast, by End-User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Platform (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.2.15. Market Revenue and Forecast, by End-User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.7. Market Revenue and Forecast, by End-User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.9. Market Revenue and Forecast, by End-User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Platform (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.7. Market Revenue and Forecast, by End-User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.9. Market Revenue and Forecast, by End-User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Platform (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.7. Market Revenue and Forecast, by End-User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Platform (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 14. Company Profiles

14.1. Sinocare Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Hoffmann La Roche Ltd

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Siemens AG

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Abott Laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. bioMrieux SA

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton Dickinson and Company

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Danaher Coraporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Nova Biomedical

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9.Sysmex corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Johnson and Johnson

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms